Covovax vaccine available for everyone above 12 years: Adar Poonawalla

Serum Institute of India seeks regular marketing authorisation from DCGI for Covishield

COVID-19: Serum Institute of India seeks approval to make Russia's Sputnik V vaccine

After row, Serum Institute cuts price of its Covid vaccine to 300 rupees for states as 'philanthropic gesture'

Covishield vaccination will go on with full vigour: India

We believe in vaccine cooperation, not competition, says Indian envoy to Russia Venkatesh Varma

Serum Institute fire: Three Maharashtra government agencies launch probe

Pfizer-BioNTech requests more time, India's SEC to meet on January 1 to authorise SII, Bharat Biotech vaccines

DCGI expert panel asks SII, BHARAT Biotech to provide more safety, efficacy data for Covid-19 vaccines

The Serum Institute of India (SII) on Sunday became the first indigenous company to apply to the Drugs Controller General of India (DCGI) seeking emergency use authorisation for the Oxford COVID-19 vaccine 'Covishield' in the country,

News Alert: Serum institute seeks emergency use nod for 'Covishield' vaccine in India

Sii, News on Sii, stories on Sii, articles on Sii, Sii stories at Wion, Sii news, Sii latest news

Latest News on Sii | Read Breaking News on Sii | Wion

sii